Development of a genetic system for combinatorial biosynthesis of lipopeptides in Streptomyces fradiae and heterologous expression of the A54145 biosynthesis gene cluster.
A54145 factors are calcium-dependent lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18160. A54145 is structurally related to the clinically important daptomycin, and as such may be a useful scaffold for the development of a novel lipopeptide antibiotic. We developed methods to genetically manipulate S. fradiae by deletion mutagenesis and conjugal transfer of plasmids from Escherichia coli. Cloning the complete pathway on a bacterial artificial chromosome (BAC) vector and the construction of ectopic trans-complementation with plasmids utilizing the φC31 or φBT1 site-specific integration system allowed manipulation of A54145 biosynthesis. The BAC clone pDA2002 was shown to harbor the complete A54145 biosynthesis gene cluster by heterologous expression in Streptomyces ambofaciens and Streptomyces roseosporus strains in yields of >100 mg/liter. S. fradiae mutants defective in LptI methyltransferase function were constructed, and they produced only A54145 factors containing glutamic acid (Glu₁₂), at the expense of factors containing 3-methyl-glutamic acid (3mGlu₁₂). This provided a practical route to produce high levels of pure Glu₁₂-containing lipopeptides. A suite of mutant strains and plasmids was created for combinatorial biosynthesis efforts focused on modifying the A54145 peptide backbone to generate a compound with daptomycin antibacterial activity and activity in Streptococcus pneumoniae pulmonary infections.
Alexander
Dylan C
DC
Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421, USA. dalexander@cubist.com
Rock
Jessica
J
He
Xiaowei
X
Brian
Paul
P
Miao
Vivian
V
Baltz
Richard H
RH
D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D001688:Biological Products / Q000096:biosynthesis / Q000235:genetics; D053898:Biosynthetic Pathways / Q000235:genetics*; D022202:Chromosomes, Artificial, Bacterial; D003227:Conjugation, Genetic; D004926:Escherichia coli / Q000235:genetics; D005816:Genetic Complementation Test; D005818:Genetic Engineering / Q000379:methods; D005822:Genetic Vectors; D005827:Genetics, Microbial / Q000379:methods; D008074:Lipoproteins / Q000096:biosynthesis / Q000235:genetics; D005810:Multigene Family; D010957:Plasmids; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism*
C065208:A54145; D000900:Anti-Bacterial Agents; D001688:Biological Products; D008074:Lipoproteins
Gene. 1996 Dec 12;183(1-2):231-6
8996112
J Antibiot (Tokyo). 1987 Jun;40(6):761-77
3610833
Chem Biol. 2006 Mar;13(3):269-76
16638532
Clin Infect Dis. 2004 Jun 15;38(12):1673-81
15227611
J Bacteriol. 1990 Jul;172(7):3790-8
2193916
Nat Prod Rep. 2005 Dec;22(6):717-41
16311632
N Engl J Med. 2006 Aug 17;355(7):653-65
16914701
J Infect Dis. 2005 Jun 15;191(12):2149-52
15898002
J Bacteriol. 1997 Jan;179(1):180-6
8981996
J Antibiot (Tokyo). 1990 Jun;43(6):587-93
2380106
J Am Chem Soc. 2007 Oct 3;129(39):12011-8
17784761
J Bacteriol. 1984 Aug;159(2):499-504
6086574
J Antibiot (Tokyo). 1990 Jun;43(6):616-22
2380110
J Bacteriol. 2003 Sep;185(17):5320-3
12923110
Microbiology (Reading). 2005 May;151(Pt 5):1507-1523
15870461
J Nat Prod. 2007 Feb;70(2):233-40
17284073
Microbiology (Reading). 1996 Sep;142 ( Pt 9):2363-73
8828204
Microbiology (Reading). 1996 Oct;142 ( Pt 10):2803-13
8885396
J Antibiot (Tokyo). 1990 Jun;43(6):601-6
2380108
Curr Opin Pharmacol. 2008 Oct;8(5):557-63
18524678
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
10829079
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17462-7
17090667
Antimicrob Agents Chemother. 2010 Apr;54(4):1404-13
20086142
Mol Microbiol. 1994 Nov;14(3):533-45
7533884
J Ind Microbiol Biotechnol. 2006 Feb;33(2):129-40
16208464
Microbiology (Reading). 2006 Oct;152(Pt 10):2993-3001
17005980
Microbiology (Reading). 2008 Sep;154(Pt 9):2872-2880
18757821
J Antibiot (Tokyo). 1990 Jun;43(6):607-15
2380109
Biosci Biotechnol Biochem. 2007 Jun;71(6):1373-86
17587668
Clin Infect Dis. 2008 Apr 15;46(8):1142-51
18444848
Chem Biol. 2002 Nov;9(11):1175-87
12445768
Curr Top Med Chem. 2008;8(8):618-38
18473888
J Ind Microbiol Biotechnol. 2006 Feb;33(2):121-8
16261359
Mol Microbiol. 2006 Sep;61(5):1294-307
16879412
J Bacteriol. 1985 Jul;163(1):180-5
4008440
Microbiology (Reading). 2003 Sep;149(Pt 9):2443-2453
12949170
J Gen Microbiol. 1981 Nov;127(1):137-46
7338732
Appl Environ Microbiol. 1990 Nov;56(11):3511-4
2268160
Nat Biotechnol. 2006 Dec;24(12):1533-40
17160059
J Antibiot (Tokyo). 1988 Aug;41(8):1093-105
2844711
J Bacteriol. 1998 Jan;180(1):143-51
9422604
Gene. 1992 Jul 1;116(1):43-9
1628843